Nls Pharmaceutics LTD. (NCEL) — 20-F Filings

All 20-F filings from Nls Pharmaceutics LTD.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.

20-F Filings (2)

NLS Pharmaceutics Files 2024 Annual Report — May 16, 2025 Risk: medium
NLS Pharmaceutics Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, incorporated in Switzerland, is involved i
NLS Pharmaceutics Ltd. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — May 15, 2024 Risk: low
NLS Pharmaceutics Ltd. (NCEL) filed a Foreign Annual Report (20-F) with the SEC on May 15, 2024. NLS Pharmaceutics Ltd. filed its annual report on Form 20-F for

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX